Talha Khan Burki. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Clinical Trials, Phase III as TopicDisease-Free SurvivalEarly Termination of Clinical TrialsFemaleHumansHysterectomy/adverse effectsHysterectomy/mortalityMinimally Invasive Surgical Procedures/adverse effectsMinimally Invasive Surgical Procedures/mortalityNeoplasm StagingRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsTime FactorsUterine Cervical Neoplasms/mortalityUterine Cervical Neoplasms/pathologyUterine Cervical Neoplasms/surgery
Year: 2018 PMID： 30416073 DOI： 10.1016/S1470-2045(18)30840-4
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316